PAVmed to Hold a Business Update Conference Call and Webcast on May 15, 2025

Rhea-AI Summary

PAVmed (Nasdaq: PAVM, PAVMZ), a diversified commercial-stage medical technology company, has announced a business update conference call and webcast scheduled for May 15, 2025, at 8:30 AM ET. During the call, Chairman and CEO Lishan Aklog, M.D., will provide a business update and overview of operations and growth strategy, while President and CFO Dennis McGrath will discuss Q1 2025 financial results.

The webcast will be accessible through PAVmed's investor relations website. U.S. callers can dial 1-800-836-8184, and international callers can dial 1-646-357-8785 to join the "PAVmed Business Update" call. A 30-day replay will be available on the company's website following the conference.

Conference Call and Webcast at 8:30 AM Eastern Time

NEW YORK, May 1, 2025 /PRNewswire/ -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, today announced that it will host a business update conference call and webcast on Thursday, May 15, 2025, at 8:30 AM ET. During the call, Lishan Aklog, M.D., PAVmed's Chairman and Chief Executive Officer, will provide a business update including an overview of the Company's operations and growth strategy. In addition, Dennis McGrath, PAVmed's President and Chief Financial Officer, will discuss the Company's first quarter 2025 financial results.

The webcast will be available at the investor relations section of the Company's website at pavmed.com.  Alternatively, to access the conference call by telephone, U.S.-based callers should dial 1-800-836-8184 and international listeners should dial 1-646-357-8785. All listeners should provide the operator with the conference call name "PAVmed Business Update" to join.

Following the conclusion of the conference call, a replay will be available for 30 days on the investor relations section of the Company's website at pavmed.com.

About PAVmed
PAVmed Inc. is a diversified commercial-stage medical technology company operating in the medical device, diagnostics, and digital health sectors. Its subsidiary, Lucid Diagnostics (Nasdaq: LUCD), is a commercial-stage cancer prevention medical diagnostics company that markets the EsoGuard^® Esophageal DNA Test and EsoCheck^® Esophageal Cell Collection Device—the first and only commercial tools for widespread early detection of esophageal precancer to mitigate the risks of esophageal cancer deaths. Its other subsidiary, Veris Health Inc., is a digital health company focused on enhanced personalized cancer care through remote patient monitoring using implantable biologic sensors with wireless communication along with a custom suite of connected external devices. Veris is concurrently developing an implantable physiological monitor, designed to be implanted alongside a chemotherapy port, which will interface with the Veris Cancer Care Platform.

For more and for more information about PAVmed, please visit pavmed.com.

For more information about Lucid Diagnostics, please visit luciddx.com.

For more information about Veris Health, please visit verishealth.com. 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/pavmed-to-hold-a-business-update-conference-call-and-webcast-on-may-15-2025-302442432.html

SOURCE PAVmed Inc.

FAQ

When is PAVmed (PAVM) hosting its Q1 2025 business update call?

PAVmed will host its business update call on Thursday, May 15, 2025, at 8:30 AM ET.

How can investors access PAVmed's (PAVM) May 2025 business update call?

Investors can access the call via webcast on PAVmed's investor relations website, or by phone: U.S. callers dial 1-800-836-8184, international callers dial 1-646-357-8785, using conference name 'PAVmed Business Update'.

Who will be presenting at PAVmed's (PAVM) Q1 2025 business update call?

CEO Lishan Aklog, M.D. will provide a business update and growth strategy overview, while President and CFO Dennis McGrath will discuss Q1 2025 financial results.

How long will the replay of PAVmed's May 2025 business update call be available?

A replay of the conference call will be available for 30 days on PAVmed's investor relations website.